Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

July 05, 2015 6:39 AM ET


Company Overview of Aimmune Therapeutics, Inc.

Executive Profile

Stephen G. Dilly M.B.B.S, Ph.D.

Chief Executive Officer and Director, Aimmune Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 5 different industries.

See Board Relationships


Dr. Stephen G. Dilly, M.B.B.S, Ph.D. serves as the Chief Executive Officer of Aimmune Therapeutics, Inc. (formerly Allergen Research Corporation). Dr. Dilly serves as Strategic Advisor at Physic Ventures, LLC. Dr. Dilly served as the Chief Executive officer of PhotoThera, Inc. from January 2012 to December 2012 and served as its President. Dr. Dilly served as Chief Executive Officer and President at APT Pharmaceutical LLC from April 2006 to December 2011. Dr. Dilly has ...

Corporate Headquarters

8000 Marina Boulevard
Brisbane, California 94005-1884

United States

Phone: 650-614-5220
Fax: 650-616-0075

Board Members Memberships

Chief Executive Officer, President and Director
Former Chief Executive Officer, President and Director
Chief Executive Officer and Director
Member of Compensation Committee and Member of Corporate Governance & Nominating Committee
Director, Chairman of Clinical Review Committee and Member of Audit Committee


PhD 1988
University Of London
Bachelor's Degree 1982
University Of London

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Aimmune Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at